More on ISIS by Jim Van Meerten
Latest ISIS Transcript
More »Latest ISIS Articles
-
Isis Pharmaceuticals Making Antisense
Mon, Jun 17 • Cory Renauer
-
Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?
Thu, Jun 13 • C.R. Jackson
-
When It Comes To Biotech, Diversity Is Key
Wed, Jun 12 • Mike Perinotti
-
Aegerion's Pricing Power Sends Shares Flying
Wed, May 22 • Brian L. Wilson
-
6 Superstars For Your Biotech Portfolio: John McCamant
Fri, May 10 • Life Sciences Report
-
Isis Pharmaceuticals Slides A Little Despite Strong Earnings
Thu, May 9 • StockBaller
-
Biotechnology: Strong Fundamentals Are The Basis Of Strong Performance
Fri, May 3 • Ryan's View
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
Isis Pharmaceuticals, Inc. (ISIS)
Posts on ISIS by Jim Van Meerten
3 Stocks Hitting New Highs
Isis Pharmaceuticals - ISIS - Barchart Chart Of The Day
Posts on ISIS by other instabloggers
-
Thu, Jun 13
•
Life Sciences Report
-
Thu, May 9
•
Life Sciences Report
-
Thu, Apr 4
•
Life Sciences Report
-
Thu, Mar 21
•
Life Sciences Report
-
Thu, Jan 31
•
Life Sciences Report
All instablog posts on ISIS »For Love And Money: Three Growth Stocks From Casey's Alex Daley
Six Superstars For Your Biotech Portfolio: John McCamant
6 Biotechs With Staggering Potential: Grant Zeng
Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
The Life Sciences Report Watchlist 2013